Insider trading

Period: 120 months Stock: TECH Minimum amount: $1M × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

62 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

62 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

62 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

62 decisions over 120 months Remove this filter
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
62 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
62 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

62 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
27 Jan 2025
Kelderman Kim Chief Executive Officer
Sold at will 2×
$1.04M 13,392 at 77.29
25.6%
Not planned
8 Aug 2024
Sold at will
$1.15M 16,000 at 72.10
26.9%
Not planned
21 Jul 2023
Kummeth Charles R. Chief Executive Officer
Sold on a plan
$7.07M 80,000 at 88.36
6.0%
Planned (10b5-1)
7 Jun 2022
Kummeth Charles R. CHIEF EXECUTIVE OFFICER
Sold, plan not stated
$1.86M 5,104 at 365.00
2.5%
12 Nov 2021
Eansor Norman David President-Protein Sciences
Sold, plan not stated 10×
$13.69M 27,159 at 504.00
95.4%
Sold half or more
1 Nov 2021
Hippel James Chief Financial Officer
Sold, plan not stated 4×
$4.64M 8,822 at 526.52
45.1%
7 Sep 2021
STEER RANDOLPH C Director
Sold, plan not stated 3×
$4.08M 8,000 at 509.98
61.0%
Sold half or more
2 Sep 2021
Hippel James Chief Financial Officer
Sold, plan not stated 2×
$5.07M 10,000 at 507.22
48.0%
2 Sep 2021
Furlow Brenda S. SVP - General Counsel
Sold, plan not stated 2×
$3.50M 6,871 at 509.94
47.4%
31 Aug 2021
Furlow Brenda S. SVP - General Counsel
Sold, plan not stated 3×
$2.53M 5,000 at 505.66
39.6%
23 Aug 2021
Sold, plan not stated 6×
$1.94M 4,000 at 485.55
29.4%
23 Aug 2021
Nusse Roeland Director
Sold, plan not stated
$1.93M 4,000 at 481.52
37.2%
19 Aug 2021
Furlow Brenda S. SVP - General Counsel
Sold, plan not stated 3×
$1.68M 3,538 at 473.95
31.7%
9 Aug 2021
Hippel James Chief Financial Officer
Sold, plan not stated 8×
$4.79M 10,000 at 478.90
48.0%
12 Jul 2021
Hippel James Chief Financial Officer
Sold, plan not stated 13×
$4.57M 10,000 at 456.67
52.3%
Sold half or more
18 Jun 2021
Kummeth Charles R. Chief Executive Officer
Sold, plan not stated 2×
$1.31M 2,909 at 449.23
1.8%
17 Jun 2021
Kummeth Charles R. Chief Executive Officer
Sold, plan not stated 4×
$4.31M 9,589 at 449.81
5.7%
14 Jun 2021
Kummeth Charles R. Chief Executive Officer
Sold, plan not stated 2×
$3.36M 7,481 at 449.15
4.3%
7 Jun 2021
Hippel James Chief Financial Officer
Sold, plan not stated 6×
$4.19M 9,942 at 421.93
52.1%
Sold half or more
12 Feb 2021
Hippel James Chief Financial Officer
Sold, plan not stated 2×
$4.00M 10,000 at 400.39
52.3%
Sold half or more
12 Feb 2021
Furlow Brenda S. SVP - General Counsel
Sold, plan not stated 2×
$3.99M 10,000 at 398.64
62.0%
Sold half or more
8 Feb 2021
Nusse Roeland Director
Sold, plan not stated
$2.31M 6,000 at 385.08
47.0%
5 Feb 2021
Eansor Norman David President-Protein Sciences
Sold, plan not stated 7×
$12.54M 32,933 at 380.68
96.2%
Sold half or more
15 Jan 2021
Kummeth Charles R. Chief Executive Officer
Sold, plan not stated
$6.88M 20,000 at 344.00
12.0%
11 Jan 2021
Hippel James Chief Financial Officer
Sold, plan not stated 6×
$3.34M 10,000 at 333.63
52.3%
Sold half or more
7 Dec 2020
Kummeth Charles R. Chief Executive Officer
Sold, plan not stated
$1.54M 5,000 at 308.00
2.9%
30 Nov 2020
Furlow Brenda S. SVP - General Counsel
Sold, plan not stated 3×
$3.28M 10,857 at 301.94
63.9%
Sold half or more
18 Nov 2020
Sold, plan not stated
$1.52M 5,000 at 303.34
34.2%
11 Nov 2020
Hippel James Chief Financial Officer
Sold, plan not stated 2×
$2.27M 7,391 at 307.05
44.7%
9 Nov 2020
Seth Alpna Director
Sold, plan not stated 2×
$1.54M 5,023 at 306.62
70.1%
Sold half or more
9 Nov 2020
Hippel James Chief Financial Officer
Sold, plan not stated 5×
$1.12M 3,600 at 309.79
28.3%
6 Nov 2020
STEER RANDOLPH C Director
Sold, plan not stated 6×
$3.02M 10,000 at 301.99
66.2%
Sold half or more
6 Nov 2020
HIGGINS JOHN L Director
Sold, plan not stated 3×
$1.50M 5,000 at 300.35
53.1%
Sold half or more
5 Nov 2020
Hippel James Chief Financial Officer
Sold, plan not stated 10×
$2.52M 8,809 at 286.12
49.1%
4 Nov 2020
Hippel James Chief Financial Officer
Sold, plan not stated 4×
$1.95M 7,100 at 274.00
43.7%
9 Jul 2020
Furlow Brenda S. SVP - General Counsel
Sold, plan not stated 8×
$2.50M 9,079 at 275.76
67.8%
Sold half or more
6 Jul 2020
Hippel James Chief Financial Officer
Sold, plan not stated 5×
$5.84M 21,502 at 271.61
69.8%
Sold half or more
29 May 2020
Eansor Norman David President-Protein Sciences
Sold, plan not stated 4×
$2.07M 7,909 at 262.00
100%
Sold half or more
29 May 2020
WIENS HAROLD J Director
Sold, plan not stated
$1.04M 3,985 at 260.00
45.1%
28 May 2020
Furlow Brenda S. SVP - General Counsel
Sold, plan not stated 2×
$1.56M 5,995 at 260.14
58.2%
Sold half or more
22 May 2020
Eansor Norman David President-Protein Sciences
Sold, plan not stated 2×
$3.38M 12,600 at 267.93
100%
Sold half or more
21 May 2020
Eansor Norman David President-Protein Sciences
Sold, plan not stated 2×
$2.95M 11,037 at 267.49
100%
Sold half or more
21 May 2020
Sold, plan not stated 4×
$1.33M 5,000 at 266.42
35.2%
6 May 2020
WIENS HAROLD J Director
Sold, plan not stated
$1.07M 4,260 at 250.00
44.9%
12 Feb 2020
HIGGINS JOHN L Director
Sold, plan not stated
$1.03M 5,000 at 205.23
55.4%
Sold half or more
6 Jan 2020
Kummeth Charles R. Chief Executive Officer
Sold, plan not stated
$2.23M 10,276 at 217.28
7.3%
3 Jan 2020
Kummeth Charles R. Chief Executive Officer
Sold, plan not stated 2×
$1.74M 7,999 at 217.56
5.8%
2 Jan 2020
Kummeth Charles R. Chief Executive Officer
Sold, plan not stated 5×
$4.34M 19,843 at 218.59
13.2%
20 Dec 2019
Kummeth Charles R. Chief Executive Officer
Sold, plan not stated 2×
$2.56M 11,534 at 222.06
8.1%
12 Dec 2019
Furlow Brenda S. SVP - General Counsel
Sold, plan not stated 4×
$1.72M 8,000 at 215.60
74.7%
Sold half or more
Showing 1–50 of 62. Page 1 of 2 Older →